Fig. 3.
Probability of cost–effectiveness at different thresholds for a comprehensive programme to treat drug-resistant tuberculosis, China, 2011–2012
US$: United States dollars.
Notes: The comprehensive programme was compared with baseline and null programmes. The comprehensive programme was considered very cost-effective if it cost less than China’s per capita gross domestic product (vertical green line) to avert a disability-adjusted life-year.5 In each plot, the grey-shaded area indicates the uncertainty around the final two-year costs and outcomes for the full cohort.
